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Abstract
Fumagillin 1 is a meroterpenoid from Aspergillus fumigatus that is known for its anti-angiogenic 
activity by binding to human methionine aminopeptidase 2. The genetic and molecular basis for 
biosynthesis of 1 had been an enigma despite the availability of the A. fumigatus genome 
sequence. Here, we reported the identification and verification of the fma gene cluster, followed 
by characterization of the polyketide synthase and acyltransferase involved in biosynthesis of the 
dioic acid portion of 1. More significantly, we uncovered the elusive β-trans-bergamotene 
synthase in A. fumigatus as a membrane-bound terpene cyclase.
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Modern genome sequencing technologies have significantly improved our abilities in 
identifying biosynthetic gene clusters of natural products. However, gene cluster assignment 
relying on homology search of enzymes catalyzing key biosynthetic transformations can 
sometimes fail, largely due to nature’s flexibility in using seemingly unrelated enzymes to 
catalyze these reactions. In these cases, the link between the natural product and the gene 
cluster cannot be easily established despite a sequenced and annotated genome. One 
example is the meroterpenoid fumagillin 1 produced by the pathogenic fungus Aspergilus 
fumigatus. Since its discovery in the 1950s,1 1 and related compounds have been intensely 
studied because of their potential use in treating amebiasis,2 microsporidiosis,3 and recently, 
their anti-angiogenic properties from the irreversible inhibition of human type 2 methionine 
aminopeptidase (MetAP2).4,5 Structurally, 1 consists of a highly oxygenated cyclohexane–
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containing terpenoid (fumagillol, 2) that is esterified with a decatetraenedioic (dioic) acid.6 
The intriguing structure of 1 has served as a total synthesis target for the last 40 years.7 The 
1,4-bis-epoxide of 2 has also been remodeled to yield new structures via a Reaction 
Discovery Approach.8 Semisynthetic analogs of 1 with modified ester group, such as 
TNP-470 (Figure 1), have under-gone clinical trials for treating different cancers.9 Hence, 
elucidating the biosynthesis of 1 can have important biomedical ramifications.
Based on the feeding study of a structurally-related compound ovalicin (Figure 1),10 2 is 
likely derived from the sesquiterpene β-trans-bergamotene 3, which can also be isolated 
from A. fumigatus.11 The enzymatic mechanism for the formation of 3 from farnesyl-PP 
(FPP) has been previously studied using cell-free extracts from the ovalicin-producing 
fungus Pseudeurotium ovalis,12,13 while the rearrangement of 3 to 2 have been probed by 
isotope incorporation studies in the context of ovalicin biosynthesis.14–17 Nevertheless, the 
genetic and molecular bases for the biosynthesis of 3, 2 and ultimately 1 have remained 
unknown. While genome sequencing of A. fumigatus Af293 provided initial hope that the 
gene cluster of 1 can be located, it was soon realized that there is no terpene cyclase 
homolog present in the entire genome.18 Because of this highly unexpected finding, the gene 
cluster has not been identified eight years after the sequencing report. More importantly, the 
lack of a terpene cyclase candidate in A. fumigatus suggests that the cyclization of FPP into 
3 must be catalyzed by a non-canonical terpene cyclase that is concealed from common 
homology search strategies. Cryptic terpene cyclases in other fungal meroterpenoid gene 
cluster have been noted.19 Here we described the verification of the gene cluster of 1, and 
identification of an integral membrane protein as the terpene cyclase responsible for the 
formation of 3 from FPP. We also provide insights into the convergent biosynthetic steps 
that bring the terpene and polyketide portions of 1 together.
Since the dioic acid moiety in 1 is mostly likely originated from a reduced polyketide 
pathway, we scanned all the highly-reducing PKS (HR-PKS) genes in the A. fumigatus 
genome and their neighboring genes. Our attention was drawn to a cluster (hereby named 
fma) containing HR-PKS gene AFUA_8G0370 (Af370) (Table S1). Most notably, the 
cluster encodes a MetAP-2 (AFUA_8G00410 or Af410) and a type 1 MetAP. Since 1 is 
known to inhibit eukaryotic MetAP-2,4 we postulated that Af410 may encode a self-resistant 
enzyme for A. fumigatus towards 1. Indeed, an additional housekeeping MetAP-2 
(AFUA_2G01750) was found in A. fumigatus, which is well-conserved among all sequenced 
aspergilli. A number of genes in the vicinity of the Af370 and Af410 also encode enzymes 
that are consistent with the structure of 1 and 2, including four oxidases (to initiate oxidative 
rearrangement of 3, to introduce the bis-epoxide, to insert the C4, C5-syn diol, and to 
oxidize the polyketide methyl terminus); a methyltransferase that may O-methylate C4-OH; 
and an α,β-hydrolase that may release or transfer the polyketide from HR-PKS to 2 (Table 
S1). Thus, despite the absence of a canonical terpene cyclase, we hypothesized that the fma 
genes in Table S1 is likely the target cluster.
We first deleted Af370 encoding the HR-PKS (named fma-PKS) in A. fumigatus CEA17 
akuB KU80 strain (pyrG89, ΔakuBKU80), which is deficient in non-homologous end joining 
(Supporting Information).20 In comparison to the isogenic control strain, the metabolic 
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profile of ΔAf370 analyzed by LC-MS showed the complete abolishment of 1 (Figure 2B) 
and the accumulation of 2 (Figure 2C), which is barely detectable in the isogenic strain. To 
further prove the role of fma-PKS, the entire 264 kDa enzyme was expressed from 
Saccharomyces cerevisiae BJ5464-NpgA, which has been used for soluble expression of 
large fungal PKSs (Supporting Information).21 The 6xHis-tagged enzyme was purified by 
Ni2+-affinity chromatography (Figure S2A). In vitro reaction with malonyl-CoA and 
NADPH resulted in a yellow product that cannot be extracted using ethyl acetate with 1% 
acetic acid (Figure S2B). This result hinted that a conjugated polyunsaturated fatty acyl 
product may be synthesized and remain attached to the fma-PKS in the absence of a 
releasing enzyme. Since the product of fma-PKS is to be transacylated to C5-hydroxyl of 2, 
we hypothesized that a dedicated acyltransferase may be involved.
In the fma gene cluster, a putative α/β hydrolase is encoded immediately downstream of 
Af370 by AFUA_8G00380 (Af380), which could be involved in PKS product release. 
Alternatively, the polyketide chain may also be transferred directly to 2 by an acyltransfease, 
such as LovD and CazE involved in the biosynthesis of lovastatin22 and chaetoviridin,23 
respectively. To examine the role of the enzyme encoded by Af380 (named fma-AT), the 
6xHis-tagged enzyme was solubly expressed from BJ5464-NpgA and purified to 
homogeneity (Figure S2A). Coincubation of fma-PKS and -AT with malonyl-CoA and 
NADPH resulted in the formation of a single yellow compound 4 that can be extracted into 
the organic phase (Figure 3A). LCMS analysis of 4 yielded a mass of 190.1 (C12H14O2), 
consistent with that of do-decapentaenoic acid (Figure 3A). Repeating the assay with 
[2-13C]-malonate and a MatB-dependent in situ malonyl-CoA regeneration system resulted 
in an increase of the m/z of 4 by 6 mu, which is a further confirmation of 4 as a hexaketide. 
Although 4 can be detected in the culture of BJ5464-NpgA co-expressing fma-PKS and –AT 
(Figure S4), the compound readily degraded and is unstable upon purification.
To examine if fma-AT can transfer the polyketide product of fma-PKS to 2, we performed 
the fma-PKS turnover assay in the presence of fma-AT and 2. Interestingly, 2 can be 
converted to a single new product 5 with the mass of 454.3 (m/z 477.1 [M+Na]+), 
corresponding to that of 2 acylated with 4. To verify the structure of 5, 2.5 mg of 2 was 
supplemented to a 50 mL yeast culture co-expressing fma-PKS and -AT (Supporting 
Information). Following two days of culturing, 1.1 mg of 5 can be purified from the culture, 
which allowed complete NMR characterization of 5 by 1 and 2D NMR, and confirmed the 
structure to be that shown in Figure 3B. To verify 5 is a true on-pathway intermediate in the 
biosynthesis of 1, ~40 μg/mL of 5 was supplied to the culture of ΔAf370 strain. Following 
two days of culturing, restoration of the biosynthesis of 1 was observed (Figure 2B). 
Collectively, our genetic and biochemical studies on fma-PKS and -AT confirm the 
involvement of these enzymes in biosynthesis of 1, and provide the first evidence for this 
being the authentic fma gene cluster.
In light of the gene cluster identification and above biochemical findings, a putative pathway 
for 1 is proposed as shown in Figure 4. The terpenoid origin of the carbon backbone of 1 via 
3 has been previously established.6,10,11 3 is cyclized from FPP via nerolidyl diphosphate 
(NPP) followed by a bisabolyl cation intermediate.12,13 However, the previously proposed 
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intermediate 9 (Route 1, Figure 4),6 was ruled out by a later 2H-NMR study via 
incorporation of deuterated mevalonates into ovalicin.16 Furthermore, the proposed 
intermediate 10 has been synthesized,14 but attempt to incorporate the isotope-labeled 10 to 
ovalicin by feeding to P. ovalis was unsuccessful.17 Thus, the biosynthesis of 3 may proceed 
via an alternative pathway, such as that in Route 2, in which an iron dependent oxygenase, 
such as AFUA_8G00480, can hydroxylate 3 at C8, followed by rearrangement of the oxo-Fe 
intermediate to yield the epoxide 11 directly. A second epoxidation step, dihydroxylation 
and O-methylation afford 2. The conversion of 2 to exclusively 5 in the presence of fma-
PKS and –AT, instead of the shorter decatetraenoate ester, is surprising. This suggests that 
formation of the dioic acid moiety in 1 may proceed via an oxidative cleavage of the 
terminal alkene in 5 to yield the dioic acid in 1 (Figure 4). Oxidative cleavage of alkene by a 
single oxygenase (either via a mono- or dioxygenase mechanism) is well-documented, as 
exemplified by the carotenoid cleavage oxygenases.24 We propose the terminal alkene in 5 
can undergo oxidative C-C bond cleavage through epoxidation to yield 6, hydrolysis to 
afford a vicinal diol 7, which can undergo cleavage to yield the aldehyde 8 and 
acetaldehyde. Final oxidation of 8 then yields 1.
Identification of the fma gene cluster enabled us to take a deeper look into the nearby genes 
for a possible terpene cyclase that may synthesize 3. The locus AFUA_8G00520 (Af0520) 
was originally annotated as encoding an integral membrane protein with 173 amino acids. 
Further conserved domain analysis and re-annotation revealed that the region encode a 267-
residue protein that contains a PFAM01040 UbiA prenyltransferase (p-hydroxybenzoic acid 
oligoprenyltransferase) domain (Supporting information). However, Af0520 only exhibits 
low homology (14–19 % protein identity/~30% similarity) to the E. coli UbiA, S. cerevisiae 
COQ2 (UbiA homolog) and other known fungal membrane bound prenyltransferases,25 and 
has almost no homology to the recently discovered membrane bound cyclase involved in 
biosynthesis of pyripyropene A19 and 3,5-dimethylorsellinic acid (DMOA)-derived 
meroterpenoids.26 Protein structure prediction indicates that Af520 is comprised of six 
transmembrane helices (Figure S5). Although only sharing minimal homology, the E. coli 
UbiA prenyltransferase has been shown to be structurally related to Class I terpene 
synthases, both of which belong to all-α helical proteins, and a 3D model for UbiA has been 
built based on N. tabacum epi-aristolochene synthases.27 Indeed, homology to the α-helical 
structures of FPP synthase can also be detected for Af520 (Figure S5). Our bioinformatic 
analysis led us to reason that Af520 may encode a new type of terpene cyclases (named fma-
TC) that may be responsible for the cyclization of FPP to 3 via the mechanism shown in 
Figure 4.
To investigate the involvement of fma-TC in the biosynthesis of 1, we inactivated the gene 
through homologous recombination in A. fumigatus akuBKU80 strain. Indeed, the resulting 
ΔAf520 mutant lost the abilities to produce 1 compared to the isogenic control strain (Figure 
5A). When 3 or 5 were supplied to the ΔAf520 strain at 100 or 40 mg/L, respectively, 
production of 1 was restored (Figure 5A), thereby directly linking fma-TC to the generation 
of 3 in A fumigatus. Next, we cloned the cDNA of fma-TC (for construction of the correct 
cDNA, see Supporting Information) into a yeast 2μ expression vector and transformed into 
BJ5464-NpgA. We reasoned that the recombinant fma-TC may be able to utilize the 
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endogenous yeast FPP to produce 3. Gratifyingly, after four days of culturing followed by 
extraction with hexane, we were able to detect the formation of a highly hydrophobic 
compound that have the same mass (204.2) as 3 using GC-MS (Figure 5B) from the yeast 
strain. In contrast, control strain that does not express fma-TC did not produce any 
detectable amount of 3. Larger scale culturing enabled us to isolate the compound at a 
purified titer of 46 mg/L. GCMS fragmentation (Figure 5E) and NMR analyses (Supporting 
Information) confirmed that the yeast-derived compound is identical to 311,14 Lastly, we 
prepared microsomal fractions from the yeast strain that overexpressed fma-TC. When 
provided with 1 mM FPP and 5 mM MgCl2, we were able to detect the near sole formation 
of 3 in vitro. With ~250 μg/mL microsomal protein, the apparent rate of formation of 3 was 
estimated to be ~ 4 μM per min. Like UbiA,27,28 the fma-TC-containing microsomes are 
unable to convert FPP into 3 in the absence of Mg2+. Collectively, these results confirmed 
that the membrane-bound fma-TC is indeed the terpene cyclase that produces 3 as an 
intermediate for 1 in A. fumigatus.
Based on the type of catalytic reaction and protein fold, terpene cyclases can be generally 
categorized in the Class I (ionization of the allylic diphosphate ester to generate an allylic 
cation) or Class II (protonation-initiated) terpene cyclases.29 The recently characterized 
cyclases in pyripyropene19 and in DMOA-derived meroterpenoid pathways26 thus formed a 
new family of membrane bound terpene cyclases that catalyze a Class II-type cyclization. 
On the other hand, fma-TC (β-tans-bergamotene synthase) uncovered in this study is a new 
membrane-bound terpene cyclase that catalyzes a Class I-type reaction. Interestingly, plants 
are known to produce several bergamotenes (α-trans-bergamotene and cis-bergamotenes) 
using soluble Class I terpene cyclases.30 Thus, this study demonstrates another intriguing 
case of convergent evolution of seemingly unrelated enzymes from different Kingdoms to 
synthesize similar products.
In conclusion, our results uncovered the elusive β-trans-bergamotene synthase as a 
membrane-bound protein in A. fumigatus. We also unveiled the roles of fma-PKS and -AT, 
which yielded an unexpected intermediate 5 in the pathway of 1. This study will form the 
basis for further investigations of the biosynthesis of 1 and open up opportunities for 
derivatization of 1 using enzymatic approaches.
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Fumagillin 1 and related compounds.
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Genetic verification of fma-PKS in the biosynthesis of 1. (A) the fma gene cluster; the 
numbers are part of the locus tag AFUA_8G00###, e.g. 370 is AFUA_8G0370. Genes are 
color-coded for polyketide biosynthesis (green), terpene cyclization (orange), tailoring 
modification (blue), self-resistance gene (red), and un-known/unassigned function (white) 
(see Table S1). (B) HPLC analysis of metabolites extracted from wild type and ΔAf370 
strain showing loss of 1 and restored production of 1 upon feeding of 5 to ΔAf370; (C) 
LCMS analysis of the ΔAf370 strain showing the accumulation of 2.
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In vitro verification of the functions of fma-PKS and fma-AT in the biosynthesis of 4 and 5. 
(A) fma-PKS synthesized the C12 polyketide product that is hydrolyzed to yield the acid 4 
by fma-AT; (B) In vitro acylation of 2 (1 mM) to yield 5 by fma-PKS and -AT.
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Putative biosynthetic pathway of 1.
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Verification of the function of Af520 encoding fma-TC and the synthesis of 3. (A) HPLC 
analysis of metabolites produced by A fumigatus upon deletion of Af520, and chemical 
complementation of ΔAf520 with 3 or 5. (B) GC-MS detection of 3 upon expression of f 
ma-TC in S. cerevisiae BJ5464-NpgA. S. c. control is untransformed BJ5464-NpgA (C) 
GC-MS analysis of in vitro assays with FPP and yeast microsomes containing fma-TC. (D) 
GC-MS spectrum of 3.
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